Long-Term Outcomes of Uveoretinitis in Behçet’s Disease in the Era of Biologic Treatments: A 10-Year Follow-Up Study
While biologic therapies, particularly TNF inhibitors, play an important role in managing refractory cases of BD uveoretinitis, our study suggests that conventional therapies such as colchicine may also provide effective long-term disease control. This highlights the importance of individualized treatment decisions, factoring in both medical and economic considerations.
Authors
- Hiroshi Gotô (ORCID: https://orcid.org/0000-0002-6462-9524)
- Kinya Tsubota (ORCID: https://orcid.org/0000-0002-7680-3745)
- Risa Sugawara
- Yoshihiko Usui (ORCID: https://orcid.org/0000-0002-1258-3587)
Institutions
- Tokyo Medical University Hospital (JP)
Publication Details
- Journal
- Ocular Immunology and Inflammation
- Published
- 2025-02-20
- DOI
- https://doi.org/10.1080/09273948.2025.2467435
- Primary Topic
- Ocular Diseases and Behçet’s Syndrome
- Type
- article
- Field-Weighted Citation Impact
- 0.00